13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001590144
Total reported value
$37.0M
$37.0M
51 檔
874.7%
According to the latest 13F quarterly dataset, Pura Vida Investments, LLC managed an equity portfolio of $37.0M at the end of Q1 2024, spanning 51 distinct U.S. exchange-listed positions.
During Q1 2024, Pura Vida Investments, LLC's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Ishares Tr | Stock-Other | 24.99% | — | — | |
| 2 | HUM | Humana Inc. | Stock-Healthcare | 10.23% | — | — | |
| 3 | ✓ | Spdr S&P 500 Etf Tr Put Option | ETF-Large Cap & Growth | 7.05% | — | — | |
| 4 | ✓ | Ishares Tr | Stock-Other | 6.51% | — | — | |
| 5 | ✓ | Exact Sciences CORP | Stock-Other | 5.76% | — | — | |
| 6 | EXK | Exact Sciences CORP | Stock-Materials | 5.61% | — | — | |
| 7 | ✓ | Spdr Series Trust | Stock-Other | 5.44% | — | — | |
| 8 | ✓ | Invesco QQQ Tr Put Option 06/2 | Stock-Other | 4.49% | — | — | |
| 9 | ✓ | Establishment Labs Holdings In | Stock-Other | 2.25% | -6.73% | -44.09% | |
| 10 | ✓ | Ark ETF Tr | ETF-Other | 1.94% | — | — | |
| 11 | ISRG | Intuitive Surgical Inc | Stock-Healthcare | 1.62% | — | -31.29% | |
| 12 | ✓ | Advisorshares Tr | Stock-Other | 1.60% | — | — | |
| 13 | QTRX | Quanterix CORP | Stock-Other | 1.49% | — | -48.59% | |
| 14 | LYRAGBP | Lyra Therapeutics Inc | Stock-Other | 1.48% | — | — | |
| 15 | ✓ | Livanova PLC | Stock-Other | 1.37% | — | — | |
| 16 | ARKK | ARK Innovation ETF | ETF-Other | 1.27% | — | — | |
| 17 | GKOS | Glaukos CORP | Stock-Healthcare | 1.26% | — | -55.74% | |
| 18 | ✓ | Guardant Health Inc | Stock-Other | 1.12% | — | — | |
| 19 | NTRA | Natera Inc | Stock-Healthcare | 1.10% | -2.26% | -49.29% | |
| 20 | MSOS | Advisorshares Pure US Cann | ETF-Other | 0.98% | — | +225.28% | |
| 21 | ✓ | Resmed Inc | Stock-Other | 0.93% | — | — | |
| 22 | LIVN | LivaNova PLC | Stock-Other | 0.85% | — | -43.55% | |
| 23 | MGX | Metagenomi Therapeutics Inc | Stock-Other | 0.82% | -1.53% | — | |
| 24 | ATEC | Alphatec Holdings Inc | Stock-Other | 0.74% | — | +4.94% | |
| 25 | LUNG | Pulmonx CORP | Stock-Other | 0.73% | — | -2.22% | |
| 26 | BHC | Bausch Health Companies Inc. | Stock-Healthcare | 0.72% | — | — | |
| 27 | DXCM | Dexcom Inc | Stock-Healthcare | 0.70% | — | +14.69% | |
| 28 | ✓ | Inspire Med Sys Inc | Stock-Other | 0.63% | — | — | |
| 29 | VKTX | Viking Therapeutics Inc | Stock-Healthcare | 0.55% | — | — | |
| 30 | ✓ | Inspire Med Sys Inc | Stock-Other | 0.54% | — | — | |
| 31 | INSP | Inspire Medical Systems Inc | Stock-Healthcare | 0.54% | — | -50.00% | |
| 32 | ELAN | Elanco Animal Health Inc | Stock-Healthcare | 0.53% | — | -15.98% | |
| 33 | SWAVUSD | Shockwave Medical Inc | Stock-Other | 0.48% | — | — | |
| 34 | ISRG | Intuitive Surgical, Inc. | Stock-Healthcare | 0.40% | — | — | |
| 35 | RGEN | Repligen CORP | Stock-Healthcare | 0.35% | — | — | |
| 36 | GH | Guardant Health Inc | Stock-Healthcare | 0.35% | — | -13.04% | |
| 37 | CUTREUR | Cutera Inc | Stock-Other | 0.27% | — | -15.09% | |
| 38 | IMDX | Insight Molecular Diagnostic | Stock-Other | 0.26% | -13.15% | -10.73% | |
| 39 | TNDM | Tandem Diabetes Care Inc | Stock-Other | 0.25% | — | -43.33% | |
| 40 | EW | Edwards Lifesciences CORP | Stock-Healthcare | 0.25% | — | — | |
| 41 | TXG | 10x Genomics Inc-class A | Stock-Other | 0.24% | — | — | |
| 42 | ✓ | Inmode LTD | Stock-Other | 0.22% | — | — | |
| 43 | BAX | Baxter International Inc | Stock-Healthcare | 0.22% | — | -70.00% | |
| 44 | ZIMV | Zimvie Inc | Stock-Other | 0.20% | — | — | |
| 45 | TMCI | Treace Medical Concepts Inc | Stock-Other | 0.20% | — | — | |
| 46 | NSPR | Inspiremd Inc | Stock-Other | 0.18% | -4.09% | — | |
| 47 | MYGN | Myriad Genetics Inc | Stock-Other | 0.16% | — | -10.55% | |
| 48 | RCEL | Avita Medical Inc | Stock-Other | 0.09% | — | -90.31% | |
| 49 | TALKW | Hudson Executive Inv -cw25 | Stock-Other | 0.01% | — | — | |
| 50 | RCKTW | Rocket Pharmaceuticals In-27 | Stock-Other | — | — | — |
According to official SEC Form 13F filings, Pura Vida Investments, LLC reported a total U.S. public equity portfolio value of $37.0M across 51 disclosed positions in Q1 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including ISHARES TR, HUM, Spdr S&P 500 Etf Tr Put Option) accounted for 874.7% of total reported equity market value during Q1 2024.
During Q1 2024, Pura Vida Investments, LLC's top holdings by market value included ISHARES TR (25.0%)、HUM (10.2%)、Spdr S&P 500 Etf Tr Put Option (7.0%). The largest single position, ISHARES TR, represented 25.0% of total portfolio value.
In Q1 2024, Pura Vida Investments, LLC made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.